Odyssey Therapeutics, Inc. (ODTX)
25.17
-1.22
(-4.62%)
USD |
NASDAQ |
Aug 24, 16:00
25.17
0.00 (0.00%)
After-Hours: 18:24
Odyssey Therapeutics Market Cap : 1.205B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.264B |
| August 20, 2026 | 1.181B |
| August 19, 2026 | 1.161B |
| August 18, 2026 | 1.051B |
| August 17, 2026 | 999.01M |
| August 14, 2026 | 992.79M |
| August 13, 2026 | 992.31M |
| August 12, 2026 | 1.033B |
| August 11, 2026 | 974.59M |
| August 10, 2026 | 1.062B |
| August 07, 2026 | 1.014B |
| August 06, 2026 | 1.032B |
| August 05, 2026 | 1.000B |
| August 04, 2026 | 955.91M |
| August 03, 2026 | 870.81M |
| July 31, 2026 | 909.23M |
| July 30, 2026 | 884.74M |
| July 29, 2026 | 866.96M |
| July 28, 2026 | 885.22M |
| July 27, 2026 | 914.04M |
| July 24, 2026 | 896.26M |
| July 23, 2026 | 848.71M |
| July 22, 2026 | 893.86M |
| July 21, 2026 | 875.13M |
| July 20, 2026 | 844.39M |
| Date | Value |
|---|---|
| July 17, 2026 | 845.83M |
| July 16, 2026 | 819.41M |
| July 15, 2026 | 828.54M |
| July 14, 2026 | 831.42M |
| July 13, 2026 | 845.83M |
| July 10, 2026 | 801.64M |
| July 09, 2026 | 808.37M |
| July 08, 2026 | 747.37M |
| July 07, 2026 | 764.18M |
| July 06, 2026 | 791.08M |
| July 02, 2026 | 806.93M |
| July 01, 2026 | 797.80M |
| June 30, 2026 | 898.67M |
| June 29, 2026 | 907.31M |
| June 26, 2026 | 867.45M |
| June 25, 2026 | 854.96M |
| June 24, 2026 | 887.14M |
| June 23, 2026 | 890.98M |
| June 22, 2026 | 899.15M |
| June 18, 2026 | 915.96M |
| June 17, 2026 | 887.62M |
| June 16, 2026 | 858.32M |
| June 15, 2026 | 832.62M |
| June 12, 2026 | 797.24M |
| June 11, 2026 | 793.00M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 5.100B |
| Alnylam Pharmaceuticals, Inc. | 31.57B |
| Anika Therapeutics, Inc. | 285.19M |
| Savara, Inc. | 1.143B |
| Vericel Corp. | 2.167B |
Market Cap Related Metrics
| PS Ratio | 419.91 |
| PEG Ratio | -0.0515 |
| Price to Book Value | 2.862 |
| Price | 25.17 |
| Earnings Yield | -14.13% |
| PEGY Ratio | -0.0515 |